this sample after subtracting the peaks due to benzimidazole
[Found: (M ϩ H)ϩ (FAB) 475.237. C24H35N4O4S (M ϩ H)
requires 475.238]; δH (300 MHz, CDCl3) Ϫ0.89 (3 H, s), 0.63
(3 H, s), 1.24 (6 H, t, J 7.2), 1.40–1.70 (6 H, m), 1.86 (1 H, dd,
J 13.8 and 8.1), 2.40 (1H, br s), 2.49 (1 H, d, J 13.8), 2.53 (1 H,
br s), 2.76 (1 H, d, J 13.8), 2.88 (1 H, br s), 3.22–3.30 (4 H, m),
5.03 (1 H, dd, J 7.8 and 3.0), 7.25–7.32 (2 H, m), 7.52–7.57 (1 H,
m), 7.75–7.80 (1 H, m) and 8.02 (1 H, s); δC (75.5 MHz, CDCl3)
14.6 (CH3), 18.1 (CH3), 19.8 (CH3), 26.7 (CH2), 29.6 (CH2),
30.3 (CH3), 30.6 (CH2), 33.5 (CH2), 38.9 (CH2), 41.6 (CH2),
44.1 (CH), 48.8 (Cq), 48.9 (Cq), 49.3 (Cq), 50.2 (CH2), 80.6
(CH), 110.4 (CH), 120.3 (CH), 122.9 (CH), 123.8 (CH), 134.2
(Cq), 137.7 (Cq), 142.7 (CH) and 168.2 (CO).
3289, 1723 and 1665; δH (300 MHz, CDCl3) 0.65 (3 H, s), 0.77
(3 H, s), 1.21 (6 H, t, J 7.2), 1.55–1.96 (7 H, m), 2.15 (1 H, br d,
J 11.4), 2.22 (1H, t, J 10.5), 2.48 (1 H, d, J 13.8), 2.70 (1 H, d,
J 13.8), 2.93 (1 H, d, J 11.4), 3.23 (4 H, q, J 7.2), 4.90–5.02 (1 H,
m), 6.24 (1 H, dd, J 3.9 and 2.7) 6.95 (1 H, dd, J 3.9 and 1.8),
7.31 (1 H, br s) and 9.25 (1 H, d, J 1.2); δC (75.5 MHz, CDCl3)
14.6 (CH3), 19.6 (CH3), 20.1 (CH3), 26.9 (CH2), 30.5 (CH2),
36.0 (CH2), 38.7 (CH2), 41.5 (CH2), 44.3 (CH), 49.1 (Cq), 49.2
(Cq), 49.5 (CH2), 52.0 (Cq), 80.1 (CH), 109.5 (CH), 124.4 (CH),
130.1 (CH), 133.0 (Cq), 169.0 (CO) and 179.0 (CO); m/z (EI)
451.
The second isomer was a white crystalline solid (0.1 g, 26%),
mp 124.9–129.1 ЊC [Found: (M ϩ H)ϩ (FAB) 452.221.
C22H34N3O5S (M ϩ H) requires 452.222]; [α]2D3 Ϫ85.6 (CH2Cl2,
1.35 g/100 ml); νmax (Nujol)/cmϪ1 3298, 1736 and 1665;
δH (300 MHz, CDCl3) 0.60 (3 H, s), 0.78 (3 H, s), 1.23 (6 H, t,
J 6.9), 1.60–2.00 (7 H, m), 2.35 (1 H, br s), 2.54 (1 H, d, J 13.8),
2.76 (1 H, d, J 9.6), 2.82 (1H, br d, J 13.8), 3.18–3.33 (4 H, m),
4.91–4.94 (1 H, m), 6.22 (1 H, dd, J 3.9 and 2.4), 6.93 (1 H, dd,
J 3.9 and 1.8), 7.05 (1 H, br s) and 9.56 (1 H, d, J 0.9); δC (75.5
MHz, CDCl3) 14.5 (CH3), 19.3 (CH3), 20.1 (CH3), 26.9
(CH2), 30.4 (CH2), 35.1 (CH2), 38.7 (CH2), 41.5 (CH2), 44.3
(CH), 49.1 (Cq), 49.2 (Cq), 49.8 (CH2), 52.3 (Cq), 80.4 (CH),
109.6 (CH), 124.3 (CH), 129.7 (CH), 133.1 (Cq), 168.1 (CO) and
178.9 (CO).
[(1R)-10-(N,N-Diethylsulfamoyl)isobornyl] 2-(5-methyl-2,4-
dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)aziridine-2-carboxylates
2f and 3f
A solution of the azide 5a (0.3 g, 0.78 mmol) in toluene (20 ml)
was heated under reflux for 1.5 h. Two thirds of the toluene
were removed and dry acetonitrile was added to make up the
original volume of solvent. Thymine (0.10 g, 0.78 mmol) and
sodium carbonate (0.5 g, 4.68 mmol) were then added. After
6 days the reaction mixture was filtered and the filtrate was
evaporated to leave an oil showing two diastereomers (2 : 1
ratio). Dry flash chromatography (hexane–ether) gave two
diastereomers in a total yield of 51%. The major isomer 3f
was isolated as a solid (0.10 g, 27%), slightly contaminated with
the minor isomer; νmax (Nujol)/cmϪ1 3284, 1719 and 1692;
δH (300 MHz, CDCl3) 0.84 (3 H, s), 0.90 (3 H, s), 1.22 (6H, t,
J 7.2), 1.6–1.94 (7 H, m), 1.94 (3 H, d, J 1.5), 2.09 (1 H, t,
J 10.5), 2.21 (1 H, d, J 10.5), 2.69 (1 H, d, J 13.8), 2.94 (1 H, d,
J 10.5), 2.97 (1 H, d, J 13.8), 3.12–3.31 (4 H, m), 5.10–5.14 (1 H,
m), 7.38 (2 H, br d, J 1.5) and 8.05 (1 H, br s); δC (75.5 MHz,
CDCl3) 12.3 (CH3), 14.5 (CH3), 19.3 (CH3), 20.0 (CH3), 26.9
(CH2), 30.0 (CH2), 30.7 (CH2), 36.0 (CH2), 38.7 (CH2), 41.4
(CH2), 44.3 (CH), 49.3 (Cq), 49.5 (Cq), 50.5 (CH2), 51.4 (Cq),
80.1 (CH), 109.9 (Cq), 139.2 (CH), 150.4 (Cq), 163.7 (CO) and
167.6 (CO).
Further elution gave the minor isomer 2f contaminated with
the major isomer (0.07 g, 19%) and a small fraction of the pure
minor isomer (0.02 g, 5%). 1H NMR data of the minor isomer:
δH (300 MHz, CDCl3) 0.86 (3 H, s), 0.88 (3 H, s), 1.23 (6 H, t,
J 7.2), 1.60–1.94 (7 H, m), 1.91 (3 H, d, J 1.2), 2.28 (1 H,
d, J 11), 2.40 (1 H, t, J 10.8), 2.63 (1 H, d, J 13.2), 2.76 (1 H, d,
J 11), 3.18–3.38 (5 H, m), 5.10–5.15 (1 H, m), 7.18 (1 H, br d,
J 1.2) and 8.12 (1H, s); δC (75.5 MHz, CDCl3) 12.3 (CH3), 14.7
(CH3), 19.6 (CH3), 20.1 (CH3), 26.9 (CH2), 29.7 (CH2), 30.3
(CH3), 36.0 (CH2), 30.4 (CH2), 34.9 (CH2), 39.0 (CH2), 41.8
(CH2), 44.3 (CH), 49.4 (Cq), 49.7 (Cq), 49.8 (CH2), 51.8 (Cq),
80.6 (CH), 110.8 (Cq), 138.8 (CH), 150.4 (CO), 163.6 (CO) and
167.0 (CO).
[(1R)-10-(N,N-Diethylsulfamoyl)isobornyl] 2-phenylaziridine-2-
carboxylates 2h and 3h
A solution of the azide 5a (0.28 g, 0.72 mmol) in toluene (15 ml)
was heated under reflux for 1.5 h. Phenylmagnesium bromide
(3M solution in ether; 1.06 ml, 0.57 mmol) was added to the
solution with stirring under nitrogen at Ϫ78 ЊC. The reaction
mixture was allowed to reach room temperature. The toluene
was then distilled off leaving a solid that was dissolved in ether,
washed with 10% aq. citric acid (2 × 50 ml) and dried. The
solution was concentrated on a rotary evaporator giving an oil
that was subjected to dry flash chromatography in hexane–
ether. The title compound was isolated as a mixture of two
diastereomers in a 1 : 1 ratio (0.10 g, 40%); δH (300 MHz,
CDCl3) 0.39 (3 H, s), 0.79 (3 H, s), 0.84 (3 H, s), 1.06 (3 H, s),
1.10 (6 H, t, J 7.2) 1.23 (6 H, t, J 6.9), 1.50–1.97 (15 H, m), 2.05
(1 H, br s), 2.39 (1 H, d, J 13.2), 2.48 (1 H, br s), 2.53 (1 H, br s),
2.54 (1 H, d, J 13.2), 2.64 (1 H, d, J 13.5), 2.80–3.00 (5 H, m),
3.28 (4 H, q, J 7.2), 4.95–5.00 (2 H, m), 7.20–7.30 (6 H, m),
7.35–7.42 (2H, m) and 7.45–7.50 (2 H, m).
Bis[(1R)-10-(N,N-Diethylsulfamoyl)isobornyl] pyrazine-2,5-
dicarboxylate 9
A solution of the azide 5a (0.26 g, 0.72 mmol) in toluene (15 ml)
was heated under reflux for 1.5 h. The solution was cooled in an
ice–water bath and benzylamine (0.08 g, 0.72 mmol) was added
under nitrogen. The reaction mixture was stirred at room
temperature for 19 h, the solvents were evaporated, and the
residual oil subjected to dry flash chromatography (hexane–
ether) to give the pyrazine 9 (90 mg, 17%), mp 238.6–241 ЊC
(from hexane–ether) (Found: C, 57.4; H, 7.7; N, 7.8.
C34H54N4O8S2 requires C, 57.4; H, 7.7; N, 7.9%); νmax (Nujol)/
cmϪ1 1746 and 1718; δH (300 MHz, CDCl3) 0.95 (6 H, s), 1.09
(12 H, t, J 7.2), 1.12 (6 H, s), 1.20–1.35 (2 H, m), 1.60–2.06
(10 H, m), 2.14 (2 H, dd, J 13.8 and 8.1), 2.75 (2 H, d, J 13.5),
3.10–3.30 (8 H, m), 3.51 (2 H, d, J 13.5), 5.31 (2 H, dd, J 8.1 and
3.6) and 9.31 (2 H, s); δC (75.5 MHz, CDCl3) 14.4 (CH3), 20.0
(CH3), 20.3 (CH3), 27.0 (CH2), 30.1 (CH2), 39.2 (CH2), 41.4
(CH2), 44.6 (CH), 49.4 (Cq), 49.5 (CH2), 49.6 (Cq), 80.3 (CH),
145.2 (CH), 145.8 (Cq) and 162.2 (CO).
[(1R)-10-(N,N-Diethylsulfamoyl)isobornyl] 2-(2-formylpyrrol-1-
yl)aziridine-2-carboxylates 2g and 3g
A solution of the azide 5a (0.34 g, 0.88 mmol) in toluene (20 ml)
was heated under reflux for 1.5 h. Two thirds of the toluene
were removed and dry acetonitrile was added to make up
the original volume of solvent. 2-Formylpyrrole (0.83 g,
0.88 mmol) and sodium carbonate (0.56 g, 5.28 mmol) were
then added. The reaction flask was kept under nitrogen with
stirring for 2 h, then filtered, and the solvent was removed from
the filtrate to leave an oil that showed the two diastereomers in a
1 : 1 ratio. Dry flash chromatography (hexane–ether) gave the
two diastereomers completely separated in a total yield of
60.5%. One isomer was isolated as white crystalline solid
(0.13 g, 34.5%), mp 160–162 ЊC (from hexane–ether) (Found:
C, 58.7; H, 7.25; N 9.1. C22H33N3O5S requires C, 58.5; H, 7.3;
N, 9.3%), [α]2D3 Ϫ62.3 (CH2Cl2, 2.4 g/100 ml); νmax (Nujol)/cmϪ1
Further elution of the column gave (R)-10-(N,N-diethyl-
sulfamoyl)isoborneol (0.07 g, 33.6%) identified by comparison
of the 1H NMR with an authentic sample.
J. Chem. Soc., Perkin Trans. 1, 2002, 1911–1919
1917